开发一种风险分层工具,用于在大型队列中对非类固醇抗炎药物过敏的风险分层
Ileana-Maria Ghiordanescu1, Iuliana Ciocănea-Teodorescu2, Rik Schrijvers3
1Laboratoire Inserm UMR1327 ISCHEMIA, Tours, France; Department of Allergy and Clinical Immunology, CHRU de Tours, Tours, France; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
概括
一个新的风险评分,CA4TCH,有助于预测非类固醇抗炎药物 (NSAID) 过敏反应. 该工具有助于对NSAID过敏症的患者风险进行分层,改善临床决策.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 临床药理学 临床药理学
- 风险评估 风险评估
背景情况:
- 非类固醇抗炎药物 (NSAID) 过敏症缺乏经过验证的风险分层工具.
- 准确的风险评估对于患者管理和诊断测试至关重要.
研究的目的:
- 开发和验证一种针对非类固醇抗炎药物 (NSAID) 过敏症的新型风险分层工具.
- 预测疑似NSAID过敏症患者的药物诱导试验 (DPT) 呈阳性结果的可能性.
主要方法:
- 对1304名有NSAID过敏史的患者进行了回顾性研究.
- 基于临床病史要素的风险评分 (CA4TCH) 的开发,采用数据驱动方法.
- 在独立的队列中对CA4TCH得分的外部验证.
主要成果:
- CA4TCH评分包括反应时间表,症状 (过敏症,呼吸道),罪祸首的NSAID (阿司匹林),并发症 (喘,亚托皮),DPT的时间,化学类数量和疹.
- 在CA4TCH的测试中,对预测阳性DPT的灵敏度为78.4%,特异性为70.4%.
- 该工具正确地识别出了很大比例的阴性受试者,并准确地分类了NSAID加重的呼吸道和皮肤疾病的患者.
结论:
- CA4TCH评分提供了个性化的NSAID过敏的风险预测.
- 它与临床专业知识和欧洲患者分拣和风险评估指南保持一致.
- CA4TCH有助于更好地管理疑似NSAID过敏的患者.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
177
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
177
Hypersensitivities
1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Allergic Drug Reactions
981
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
981
Analysis of Population Pharmacokinetic Data
389
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
389


